Table 3.
Propensity score matched model results of probability of treatment with proton pump inhibitors during one year of follow-up
| Characteristics | Estimates | Odds ratio (95% CI) | P value |
|---|---|---|---|
| Age | −0.01 | 0.99 (0.95 to 1.03) | 0.56 |
| Year | 0.17 | 1.18 (1.17 to 1.20) | <0.001 |
| Male sex | −0.17 | 0.85 (0.79 to 0.91) | <0.001 |
| Income group | −0.08 | 0.92 (0.89 to 0.95) | <0.001 |
| Percutaneous coronary intervention | 0.22 | 1.25 (1.07 to 1.45) | 0.005 |
| Medical condition: | |||
| Shock | 0.46 | 1.59 (1.17 to 2.17) | 0.003 |
| Diabetes with complications | −0.18 | 0.83 (0.69 to 1.00) | 0.05 |
| Peptic ulcer | 2.18 | 8.86 (6.64 to 11.82) | <0.001 |
| Pulmonary oedema | −0.16 | 0.85 (0.63 to 1.15) | 0.30 |
| Cerebral vascular disease | 0.24 | 1.27 (1.09 to 1.48) | 0.003 |
| Cancer | 0.43 | 1.53 (0.94 to 2.48) | 0.08 |
| Cardiac dysrhythmias | −0.08 | 0.92 (0.82 to 1.03) | 0.14 |
| Acute renal failure | 0.61 | 1.85 (1.29 to 2.64) | <0.001 |
| Chronic renal failure | 0.94 | 2.58 (1.93 to 3.46) | <0.001 |
| Prescribed drugs: | |||
| Loop diuretics | 0.33 | 1.39 (1.28 to 1.50) | <0.001 |
| Spironolacton | 0.14 | 1.16 (1.03 to 1.29) | 0.01 |
| Statin | −0.05 | 0.95 (0.88 to 1.03) | 0.25 |
| β blocker | −0.01 | 0.99 (0.92 to 1.08) | 0.88 |
| ACE inhibitor | −0.07 | 0.93 (0.88 to 0.99) | 0.01 |
| Antidiabetes drugs | 0.10 | 1.10 (0.98 to 1.24) | 0.12 |
| Vitamin K antagonist | −0.09 | 0.91 (0.80 to 1.05) | 0.19 |
ACE=angiotensin converting enzyme.